1) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature (Nat Commun 2018 9(1):2981) designated by the DEPOSITOR is requested. 2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, citations of literature designated by the mKO2-Developer (Karasawa, S. et al., Biochem. J. 381 (Pt 1): 307-312, 2004) or an acknowledgment to the mKO2-Developer is requested. A RECIPIENT who belongs to a non-profit organization may use the BIOLOGICAL RESOURCE for an academic research that is non-commercial. The RECIPIENT who belongs to commercial organization should obtain written approval from the mKO2-Developer prior to MTA.
使用条件(日)
1) 研究成果の公表にあたって寄託者の指定する文献(Nat Commun 2018 9(1):2981) を引用する。2) この細胞には、マーカー遺伝子mKusabiraOrange2 (mKO2)が内包されている。利用者は、研究成果の公表にあたってmKO2開発者の指定する文献 (Karasawa, S. et al., Biochem. J. 381 (Pt 1): 307-312, 2004) の引用、もしくは、謝辞の表明を必要とする。非営利機関での学術研究目的での利用に限る。営利機関の利用者もしくは商業利用の場合はmKO2開発者から事前にその旨の提供承諾を取得する。
RIKEN Center for Brain Science Laboratory for Cell Function Dynamics Hirosawa 2-1, Wako, Saitama 351-0198 Japan
Dr.MIYAWAKI Atsushi
Fax. +81-48-467-5924 E-mail. mta-cfds@ml.riken.jp
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
17488
Kuchimaru T, Kataoka N, Nakagawa K, Isozaki T, Miyabara H, Minegishi M, Kadonosono T, Kizaka-Kondoh S.
A reliable murine model of bone metastasis by injecting cancer cells through caudal arteriesNat Commun
2018
9(1):2981
PubMed ID: 30061695
DOI: 10.1038/s41467-018-05366-3